These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 20388353
1. [Progress on study of treatment of age-related macular degeneration by pigment epithelial-derived factor]. Hou HY, Wang YS. Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):181-5. PubMed ID: 20388353 [Abstract] [Full Text] [Related]
2. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Rasmussen H, Chu KW, Campochiaro P, Gehlbach PL, Haller JA, Handa JT, Nguyen QD, Sung JU. Hum Gene Ther; 2001 Nov 01; 12(16):2029-32. PubMed ID: 11727737 [Abstract] [Full Text] [Related]
3. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, Lam DS. Am J Ophthalmol; 2006 Mar 01; 141(3):456-62. PubMed ID: 16490490 [Abstract] [Full Text] [Related]
4. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. Ohno-Matsui K, Morita I, Tombran-Tink J, Mrazek D, Onodera M, Uetama T, Hayano M, Murota SI, Mochizuki M. J Cell Physiol; 2001 Dec 01; 189(3):323-33. PubMed ID: 11748590 [Abstract] [Full Text] [Related]
5. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Ogata N, Wada M, Otsuji T, Jo N, Tombran-Tink J, Matsumura M. Invest Ophthalmol Vis Sci; 2002 Apr 01; 43(4):1168-75. PubMed ID: 11923262 [Abstract] [Full Text] [Related]
6. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Tong JP, Yao YF. Clin Biochem; 2006 Mar 01; 39(3):267-76. PubMed ID: 16409998 [Abstract] [Full Text] [Related]
7. [The molecular mechanisms of neovascular age-related macular degeneration]. Miller DW, Joussen AM, Holz FG. Ophthalmologe; 2003 Feb 01; 100(2):92-6. PubMed ID: 12589451 [Abstract] [Full Text] [Related]
8. [Pigment epithelium-derived factor and its application in retinal angiogenic diseases]. Liu H, Su GF. Zhonghua Yan Ke Za Zhi; 2007 Nov 01; 43(11):1043-7. PubMed ID: 18307952 [Abstract] [Full Text] [Related]
9. [Pharmacological therapy for age-related macular degeneration. Current developments and perspectives]. Holz FG, Miller DW. Ophthalmologe; 2003 Feb 01; 100(2):97-103. PubMed ID: 12589452 [Abstract] [Full Text] [Related]
10. The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder? Craword SE, Fitchev P, Veliceasa D, Volpert OV. Expert Opin Drug Discov; 2013 Jul 01; 8(7):769-92. PubMed ID: 23642051 [Abstract] [Full Text] [Related]
11. Met72Thr polymorphism of pigment epithelium-derived factor gene and susceptibility to age-related macular degeneration. Yamagishi S, Nakamura K, Inoue H, Takeuchi M. Med Hypotheses; 2005 Jul 01; 64(6):1202-4. PubMed ID: 15823717 [Abstract] [Full Text] [Related]
12. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Ferrara N, Damico L, Shams N, Lowman H, Kim R. Retina; 2006 Oct 01; 26(8):859-70. PubMed ID: 17031284 [Abstract] [Full Text] [Related]
13. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Ek ET, Dass CR, Choong PF. Trends Mol Med; 2006 Oct 01; 12(10):497-502. PubMed ID: 16962374 [Abstract] [Full Text] [Related]
14. Pigment epithelium-derived factor as an impending therapeutic agent against vascular epithelial growth factor-driven tumor-angiogenesis. Manalo KB, Choong PF, Dass CR. Mol Carcinog; 2011 Feb 01; 50(2):67-72. PubMed ID: 21229603 [Abstract] [Full Text] [Related]
15. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K, Katai M, Yan L, Suzuma K, West K, Davarya S, Tong P, Gehlbach P, Pearlman J, Crabb JW, Aiello LP, Campochiaro PA, Zack DJ. Invest Ophthalmol Vis Sci; 2002 Mar 01; 43(3):821-9. PubMed ID: 11867604 [Abstract] [Full Text] [Related]
16. PEDF and VEGF plasma level alterations in patients with dry form of age-related degeneration--a possible link to the development of the disease. Machalińska A, Safranow K, Mozolewska-Piotrowska K, Dziedziejko V, Karczewicz D. Klin Oczna; 2012 Mar 01; 114(2):115-20. PubMed ID: 23346798 [Abstract] [Full Text] [Related]
17. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Duh EJ, Yang HS, Haller JA, De Juan E, Humayun MS, Gehlbach P, Melia M, Pieramici D, Harlan JB, Campochiaro PA, Zack DJ. Am J Ophthalmol; 2004 Apr 01; 137(4):668-74. PubMed ID: 15059706 [Abstract] [Full Text] [Related]
18. Role of pigment epithelium-derived factor on proliferation and migration of choroidal capillary endothelium induced by vascular endothelial growth factor in vitro. Wang FH, Sun XD, Zhang X, Xu X, Zhu Q, Huang JN, Fan Y, Gu Q, Liu HY. Chin Med J (Engl); 2007 Sep 05; 120(17):1534-8. PubMed ID: 17908464 [Abstract] [Full Text] [Related]
19. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Holekamp NM, Bouck N, Volpert O. Am J Ophthalmol; 2002 Aug 05; 134(2):220-7. PubMed ID: 12140029 [Abstract] [Full Text] [Related]
20. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma. Ek ET, Dass CR, Contreras KG, Choong PF. J Orthop Res; 2007 Dec 05; 25(12):1671-80. PubMed ID: 17600821 [Abstract] [Full Text] [Related] Page: [Next] [New Search]